Open Access<p>Canadian Medication Cost Savings Associated with Combinatorial Pharmacogenomic Guidance for Psychiatric Medications</p>
Author(s) -
JulieAnne Tanner,
Lisa Brown,
Kunbo Yu,
James Li,
Bryan Dechairo
Publication year - 2019
Publication title -
clinicoeconomics and outcomes research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.591
H-Index - 27
ISSN - 1178-6981
DOI - 10.2147/ceor.s224277
Subject(s) - formulary , medicine , medical prescription , pharmacogenomics , pharmacy , antipsychotic , psychiatry , test (biology) , family medicine , schizophrenia (object oriented programming) , pharmacology , paleontology , biology
To estimate Canadian pharmacy cost savings associated with psychiatric medication prescribing that is guided by combinatorial pharmacogenomic testing in patients switching or augmenting their psychiatric medication.